High Pointe Capital Management’s GSK GSK Stock Holding History

High Pointe Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-5,640	Closed	-$324K	–	165
2014 Q3	$324K	Sell	5,640 -26,680	-83%	-$1.64M	0.14%	156
2014 Q2	$2.16M	Buy	32,320 +120	+0.4%	+$8.12K	0.79%	62
2014 Q1	$2.15M	Buy	32,200 +5,520	+21%	+$373K	0.83%	52
2013 Q4	$1.78M	Sell	26,680 -8,464	-24%	-$549K	0.7%	73
2013 Q3	$2.2M	Hold	35,144	–	–	0.89%	48
2013 Q2	$2.19M	Buy	+35,144	New	+$2.23M	0.96%	29

Other funds holding GSK

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

High Pointe Capital Management's GSK Position: Q4 2014 in Review

High Pointe Capital Management sold out of GSK (GSK) in Q4 2014, closing a stake of 5,640 shares — an estimated $324K sold.

High Pointe Capital Management first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $2.2M in Q3 2013. 728 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

High Pointe Capital Management reported no remaining GSK position as of Q4 2014 after selling out during the quarter.
High Pointe Capital Management sold 5,640 GSK shares in Q4 2014, an estimated $324K.
High Pointe Capital Management first reported a position in GSK in Q2 2013 and held it in 6 quarters.
High Pointe Capital Management's GSK position peaked at $2.2M in Q3 2013.
728 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on High Pointe Capital Management's 13F filing for Q4 2014, filed 29 Jan 2015.